Philips Launches Duo Venous Stent System For Treatment Of Symptomatic Venous Outflow Obstruction In Patients With CVI

Sanger Heart & Vascular Institute, Atrium Health, treated the first patient with the new implantable medical device following FDA premarket approval

Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA))))), a global leader in health technology, today announced the first implant of the Duo Venous Stent System, an implantable medical device indicated to treat symptomatic venous outflow obstruction in patients with chronic venous insufficiency (CVI), following premarket approval (PMA) from the U.S. Food and Drug Association (FDA).